Present and future in vitro approaches for drug metabolism. (Q30328045)

18 June 2017

1 reference

title

Present and future in vitro approaches for drug metabolism. (English)

1 reference

18 June 2017

Ekins S

1 reference

18 June 2017

Ring BJ

1 reference

18 June 2017

Grace J

1 reference

18 June 2017

McRobie-Belle DJ

1 reference

18 June 2017

Wrighton SA

1 reference

18 June 2017

publication date

1 July 2000

1 reference

Journal of Pharmacological and Toxicological Methods

18 June 2017

published in

1 reference

18 June 2017

1 reference

18 June 2017

1 reference

18 June 2017

page(s)

313-324

1 reference

Liver slices in dynamic organ culture. I. An alternativein vitrotechnique for the study of rat hepatic drug metabolism

18 June 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8719%2800%2900110-6

7 January 2021

Liver slices in dynamic organ culture. II. Anin vitrocellular technique for the study of integrated drug metabolism using human tissue

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8719%2800%2900110-6

7 January 2021

Policy forum: intellectual property rights. Reforming the patent system

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8719%2800%2900110-6

7 January 2021

High-yield preparation of isolated rat liver parenchymal cells: a biochemical and fine structural study

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8719%2800%2900110-6

7 January 2021

Functions and transcriptional regulation of PAH-inducible human UDP-glucuronosyltransferases

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8719%2800%2900110-6

7 January 2021

Usefulness of statistic experimental designs in enzymology: example with recombinant hCYP3A4 and 1A2

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8719%2800%2900110-6

7 January 2021

Virtual kinetics: using statistical experimental design for rapid analysis of enzyme inhibitor mechanisms

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8719%2800%2900110-6

7 January 2021

Sparse sampling for assessment of drug exposure in toxicological studies.

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8719%2800%2900110-6

7 January 2021

Description of a 96-well plate assay to measure cytochrome P4503A inhibition in human liver microsomes using a selective fluorescent probe

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8719%2800%2900110-6

7 January 2021

Validation of higher-throughput high-performance liquid chromatography/atmospheric pressure chemical ionization tandem mass spectrometry assays to conduct cytochrome P450s CYP2D6 and CYP3A4 enzyme inhibition studies in human liver microsomes

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8719%2800%2900110-6

7 January 2021

Microtiter plate assays for inhibition of human, drug-metabolizing cytochromes P450

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8719%2800%2900110-6

7 January 2021

Use of cDNA-Expressed Human Cytochrome P450 Enzymes to Study Potential Drug-Drug Interactions

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8719%2800%2900110-6

7 January 2021

A commentary on the use of hepatocytes in drug metabolism studies during drug discovery and development

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8719%2800%2900110-6

7 January 2021

Concomitant toxicokinetics: techniques for and interpretation of exposure data obtained during the conduct of toxicology studies

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8719%2800%2900110-6

7 January 2021

Drug-drug interactions related to hospital admissions in older adults: a prospective study of 1000 patients

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8719%2800%2900110-6

7 January 2021

Past, present, and future applications of precision-cut liver slices for in vitro xenobiotic metabolism

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8719%2800%2900110-6

7 January 2021

Examination of purported probes of human CYP2B6.

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8719%2800%2900110-6

7 January 2021

The role of CYP2B6 in human xenobiotic metabolism

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8719%2800%2900110-6

7 January 2021

Evidence that serine 304 is not a key ligand-binding residue in the active site of cytochrome P450 2D6.

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8719%2800%2900110-6

7 January 2021

Long-term primary cultures of adult human hepatocytes

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8719%2800%2900110-6

7 January 2021

Amino acid 305 determines catalytic center accessibility in CYP3A4.

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8719%2800%2900110-6

7 January 2021

Merits and limitations of recombinant models for the study of human P450-mediated drug metabolism and toxicity: an intralaboratory comparison.

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8719%2800%2900110-6

7 January 2021

Use of precision-cut liver slices as an in vitro tool for evaluating liver function

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8719%2800%2900110-6

7 January 2021

Use of Fresh and Cryopreserved Human Liver Slices in Toxicology with Special Reference to In vitro Induction of Cytochrome P450

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8719%2800%2900110-6

7 January 2021

The study of xenobiotic-metabolizing enzymes and their role in toxicity in vivo using targeted gene disruption

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8719%2800%2900110-6

7 January 2021

Role of gene knockout mice in understanding the mechanisms of chemical toxicity and carcinogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8719%2800%2900110-6

7 January 2021

Influence of alginate gel entrapment and cryopreservation on survival and xenobiotic metabolism capacity of rat hepatocytes

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8719%2800%2900110-6

7 January 2021

Cryopreserved primary hepatocytes as a constantly available in vitro model for the evaluation of human and animal drug metabolism and enzyme induction

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8719%2800%2900110-6

7 January 2021

Evaluation of atypical cytochrome P450 kinetics with two-substrate models: evidence that multiple substrates can simultaneously bind to cytochrome P450 active sites

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8719%2800%2900110-6

7 January 2021

A new instrument for the rapid preparation of tissue slices

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8719%2800%2900110-6

7 January 2021

Preclinical evaluation of drug-drug interaction potential: present status of the application of primary human hepatocytes in the evaluation of cytochrome P450 induction.

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8719%2800%2900110-6

7 January 2021

Automation of metabolic stability studies in microsomes, cytosol and plasma using a 215 Gilson liquid handler

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8719%2800%2900110-6

7 January 2021

Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8719%2800%2900110-6

7 January 2021

Characterization of transgenic mouse strains using six human hepatic cytochrome P450 probe substrates

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8719%2800%2900110-6

7 January 2021

Fully automated analysis of activities catalysed by the major human liver cytochrome P450 (CYP) enzymes: assessment of human CYP inhibition potential

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8719%2800%2900110-6

7 January 2021

The P450 superfamily: update on new sequences, gene mapping, and recommended nomenclature

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8719%2800%2900110-6

7 January 2021

Liver slices in in vitro pharmacotoxicology with special reference to the use of human liver tissue

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8719%2800%2900110-6

7 January 2021

Selection and characterization of human cytochrome P450 1A2 mutants with altered catalytic properties

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8719%2800%2900110-6

7 January 2021

Effect of some indole derivatives on xenobiotic metabolism and xenobiotic-induced toxicity in cultured rat liver slices

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8719%2800%2900110-6

7 January 2021

Preclinical drug metabolism in the age of high-throughput screening: an industrial perspective

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8719%2800%2900110-6

7 January 2021

Chapter 4 Preparation of Isolated Rat Liver Cells

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8719%2800%2900110-6

7 January 2021

Forecasting individual pharmacokinetics

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8719%2800%2900110-6

7 January 2021

Human cytochrome P450s: selectivity and measurement in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8719%2800%2900110-6

7 January 2021

Dynamic organ culture of precision liver slices for in vitro toxicology.

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8719%2800%2900110-6

7 January 2021

Cytochrome P-450 purified to apparent homogeneity from phenobarbital-induced rabbit liver microsomes: catalytic activity and other properties

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8719%2800%2900110-6

7 January 2021

Heterologous expression of cytochrome P-450 in Escherichia coli

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8719%2800%2900110-6

7 January 2021

Metabolite kinetics of ondansetron in rat. Comparison of hepatic microsomes, isolated hepatocytes and liver slices, with in vivo disposition

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8719%2800%2900110-6

7 January 2021

Inhibition of human CYP3A catalyzed 1'-hydroxy midazolam formation by ketoconazole, nifedipine, erythromycin, cimetidine, and nizatidine

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8719%2800%2900110-6

7 January 2021

The use of in vitro metabolism techniques in the planning and interpretation of drug safety studies

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8719%2800%2900110-6

7 January 2021

The human hepatic cytochromes P450 involved in drug metabolism

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8719%2800%2900110-6

7 January 2021

In vitro methods for assessing human hepatic drug metabolism: their use in drug development

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8719%2800%2900110-6

7 January 2021

Automated high throughput human CYP isoform activity assay using SPE-LC/MS method: application in CYP inhibition evaluation

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8719%2800%2900110-6

7 January 2021

10.1016/S1056-8719(00)00110-6

Identifiers

DOI

1 reference

18 June 2017

1 reference